Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]

7310 reported adverse events

Drugs of this class: IMIGLUCERASE TALIGLUCERASE ALFA VELAGLUCERASE ALFA

These side effects are most commonly reported by patients taking drugs of the Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] class:

# Side effect Count
0 FATIGUE 404
1 PYREXIA 371
2 DEATH 322
3 FALL 311
4 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 304
5 PRODUCT DOSE OMISSION ISSUE 296
6 MALAISE 290
7 WEIGHT INCREASED 288
8 PNEUMONIA 274
9 ARTHRALGIA 265
See all common reactions for Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]

Drugs of the Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GAUCHER'S DISEASE 48 0.8727
1 CHITOTRIOSIDASE INCREASED 44 0.7213
2 BONE INFARCTION 41 0.0899
3 HEPATOSPLENOMEGALY 34 0.0132
4 SPLEEN DISORDER 22 0.0130
5 POOR VENOUS ACCESS 132 0.0127
6 MYOCLONIC EPILEPSY 17 0.0112
7 PARKINSON'S DISEASE 23 0.0090
8 DENGUE FEVER 18 0.0078
9 SPLENOMEGALY 86 0.0073
See all enriched reactions for Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]